newsfilter
← Latest News
Business Wire·

Merrimack Reports Second Quarter 2022 Financial Results

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) [("Merrimack" or the "Company")] today announced its second quarter 2022 financial results for the period ended June 30, 2022. "We are pleased to report continued reductions in operating expenses as we re